Clinical trials
Weight Loss trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 3 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 3 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
| Active, not recruiting | 2 |
| Terminated | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Maastricht University Medical Center | 5 |
| Rijnstate Hospital | 3 |
| Erasmus Medical Center | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Boston Scientific Corporation | 1 |
| Catharina Ziekenhuis Eindhoven | 1 |
| Marc van Det | 1 |
| OBEcure Ltd. | 1 |
| Radboud University Medical Center | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Weight Loss | 19 |
| Obesity | 13 |
| Obesity, Morbid | 3 |
| Overweight | 3 |
| Insulin Resistance | 2 |
| Metabolic Syndrome | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Agnosia | 1 |
| Atrial Fibrillation | 1 |
| Body Weight | 1 |
Trials
Showing 51 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.